Abstract
As biotechnologies are increasingly specialized and interrelated, the research question posed by this study is: what determines a biotechnology firm's product performance, if the development and commercialization of drug products require multiple technologies that are not possessed by any one firm? In drawing on concepts from strategic alliance and absorptive capacity research, this study develops and empirically examines a concept of 'absorptive link' in the biotechnology industry. A firm's absorptive link underscores that a firm's ability to develop new products stems from its prior knowledge in commercializing new applications of resources held by not only the firm, but also that of its alliance partners. Such a concept generated 6 testable hypotheses to which were mostly supported in this study's Poisson regression analysis of the biotechnology industry. This study concludes by offering three key contributions to product performance research.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
